Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA: 688266)
China
· Delayed Price · Currency is CNY 68.60
+0.44 (0.65%)
Nov 13, 2024, 3:00 PM CST
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Revenue
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. had revenue of 143.42M CNY in the quarter ending September 30, 2024, with 130.67% growth. This brings the company's revenue in the last twelve months to 488.45M, up 26.37% year-over-year. In the year 2023, Suzhou Zelgen Biopharmaceuticals Co.,Ltd. had annual revenue of 386.44M with 27.83% growth.
Revenue (ttm)
488.45M
Revenue Growth
+26.37%
P/S Ratio
37.16
Revenue / Employee
563.38K
Employees
867
Market Cap
18.16B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition